1. 'A novel approach for characterisation of KSHV‐associated multicentric Castleman disease from effusions': Response. (16th February 2023) Authors: Zhou, Ting; Yuan, Constance M.; Lurain, Kathryn; Stetler‐Stevenson, Maryalice; Filie, Armando C.; Pittaluga, Stefania; Jaffe, Elaine S.; Ramaswami, Ramya; Yarchoan, Robert; Wang, Hao‐Wei Journal: British journal of haematology Issue: Volume 201:Number 2(2023) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours. (December 2019) Authors: Sharma, Rohini; Wang, Wai Meng; Yusuf, Siraj; Evans, Joanne; Ramaswami, Ramya; Wernig, Florian; Frilling, Andrea; Mauri, Francesco; Al-Nahhas, Adil; Aboagye, Eric O.; Barwick, Tara D. Journal: Radiotherapy and oncology Issue: Volume 141(2019) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A novel approach for characterization of KSHV‐associated multicentric Castleman disease from effusions. (20th October 2022) Authors: Zhou, Ting; Yuan, Constance M.; Lurain, Kathryn; Rous, Clarissa; Weaver, Linda; Raffeld, Mark; Stetler‐Stevenson, Maryalice; Uldrick, Thomas S.; Filie, Armando C.; Pittaluga, Stefania; Jaffe, Elaine S.; Marshall, Vickie; Moore, Kyle; Whitby, Denise; Ramaswami, Ramya; Yarchoan, Robert; Wang, Hao‐Wei Journal: British journal of haematology Issue: Volume 200:Number 4(2023) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Activity of eribulin mesylate in heavily pretreated breast cancer granted accessvia the Cancer Drugs Fund. (February 2014) Authors: Ramaswami, Ramya; O'Cathail, Sean M; Brindley, James H; Silcocks, Paul; Mahmoud, Sarah; Palmieri, Carlo Journal: Future oncology Issue: Volume 10:Number 3(2014) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Activity of eribulin mesylate in heavilypretreated breast cancer granted accessvia the Cancer Drugs Fund. (February 2014) Authors: Ramaswami, Ramya; O'Cathail, Sean M; Brindley, James H; Silcocks, Paul; Mahmoud, Sarah; Palmieri, Carlo Journal: Future oncology Issue: Volume 10:Number 3(2014) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Altered cytochrome 2E1 and 3A P450‐dependent drug metabolism in advanced ovarian cancer correlates to tumour‐associated inflammation. (5th August 2019) Authors: Trousil, Sebastian; Lee, Patrizia; Edwards, Robert J.; Maslen, Lynn; Lozan‐Kuehne, Jingky P.; Ramaswami, Ramya; Aboagye, Eric O.; Clarke, Stephen; Liddle, Christopher; Sharma, Rohini Journal: British journal of pharmacology Issue: Volume 176:Number 18(2019) Page Start: 3712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases. (15th November 2022) Authors: Hansen, Megan E.; Mangusan, Ralph; Lurain, Kathryn; Odeny, Thomas; George, Jomy; Lu, Crystal; Manion, Maura; Widell, Anaida; Ekwede, Irene; Whitby, Denise; Gulley, James L.; Kadri, Sameer S.; Elinoff, Jason M.; Barochia, Amisha; Torabi-Parizi, Parizad; Uldrick, Thomas S.; Yarchoan, Robert; Ramasw... Journal: AIDS Issue: Volume 36:Number 14(2022) Page Start: 1969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease. (31st December 2023) Authors: Shrestha, Prabha; Astter, Yana; Davis, David A.; Zhou, Ting; Yuan, Constance M.; Ramaswami, Ramya; Wang, Hao-Wei; Lurain, Kathryn; Yarchoan, Robert Journal: Oncoimmunology Issue: Volume 12:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples. Issue 2 (30th June 2020) Authors: Cornejo Castro, Elena M; Marshall, Vickie; Lack, Justin; Lurain, Kathryn; Immonen, Taina; Labo, Nazzarena; Fisher, Nicholas C; Ramaswami, Ramya; Polizzotto, Mark N; Keele, Brandon F; Yarchoan, Robert; Uldrick, Thomas S; Whitby, Denise Journal: Virus evolution Issue: Volume 6:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer. Issue 9 (2nd September 2022) Authors: Odeny, Thomas A; Lurain, Kathryn; Strauss, Julius; Fling, Steven P; Sharon, Elad; Wright, Anna; Martinez-Picado, Javier; Moran, Teresa; Gulley, James L; Gonzalez-Cao, Maria; Uldrick, Thomas S; Yarchoan, Robert; Ramaswami, Ramya Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗